Top gainers and losers today: Stocks that moved the most on January 24

The biggest gainer was Hindustan Unilever (HUL), with a price increase of 2 percent, while Dr Reddy's Labs was the biggest loser, with a price decline of 5.04 percent

The broader market faced significant pressure today on January 24, with the Sensex closing at 76,190.46, down by 0.43 percent, and the Nifty 50 closing at 23,092.2 which meant a decline of 0.49 percent.

The biggest gainer was Hindustan Unilever (HUL), with a price increase of 2 percent, while Dr Reddy's Labs was the biggest loser, with a price decline of 5.04 percent.

The Nifty FMCG sector emerged as the best performer, closing at 56069.3 with a positive change of 0.52 percent. In contrast, the Nifty Pharma sector was the worst performer, closing at 21,872.40 with a negative change of 2.11 percent.

Mphasis Ltd shares gained over 4 percent on January 24 after the mid-tier IT firm reported its December quarter results. Mphasis' Q3FY25 revenue stood at Rs 3,561 crore, which is 6.69 percent higher than last year. The company's consolidated net profit grew nearly 15 percent to Rs 428 crore ($49.54 million) for the quarter, and a percent higher on YoY basis.

Shares of telecommunications player Indus Tower gained two percent in the morning session on January 24, after its reporting better-than-expected earnings for the quarter ended December (Q3) of the current financial year (FY25)

Shares of Thyrocare Technologies jumped over 6 percent in early trade on January 24 to hit an intraday high of Rs 867.95 apiece. This comes after the diagnostics company reported a 24 percent year-on-year rise in net profit to Rs 19.11 crore in the October-December quarter of FY25.

Shriram Finance shares traded flat on Friday ahead of the company’s third-quarter results announcement later in the day. The stock of the flagship company of diversified conglomerate Shriram Group opened with a gap-up gain of 2.56 percent and touched an intraday high of Rs 541.80 on the NSE, registering a 4.46 percent rise.

Paytm share price recovered partially after dropping more than 8 percent in January 24 trade on buzz of ED probe in crypto scam. The company, however, clarified in a stock exchange filing that it did not receive any such query from ED.

The shares of Dr Reddy's Laboratories recorded a 6 percent fall in the drugmaker's stock on January 24, a day after the release of its Q3 earnings. While drugmaker Dr Reddy's Laboratories' Q3 earnings were slightly above the Street's estimates.

Granules India shares declined beyond 3.5 percent on Friday, January 24, following the announcement of its weak Q3FY25 earnings. It registered a 6.4 percent year-on-year fall in net profit to Rs 118 crore.

Shares of Gland Pharma fell 3.17 percent to trade at Rs 1,571, as seen at 1:27 pm on January 24. This comes after the National Stock Exchange (NSE) said that it will be excluding shares of Gland Pharma from the Futures & Options (F&O) segment.

Shares of Mankind Pharma plunged nearly 6 percent on January 24, weighed down by a fall in the company's October-December net profit. The company's bottomline dropped over 16 percent on year in Q3 to Rs 385 crore, dented by a sharp rise in expenses.

Shares of Cyient took a strong beating on January 24, plummeting over 19 percent amid a slew of negative triggers for the company. The IT company's weak Q3 numbers dented sentiment, slashing its FY25 revenue growth guidance to -2.7 percent against the previous expectation of flattish growth.